Meet the Author

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

Articles by Francesca Gan

12.01.2024 | Article

Junior doctors’ strikes: Overwhelming support from HCPs online

Looking at the online HCP conversation regarding sentiments towards the junior doctor strike

By Francesca Gan

Conversation network of HCPs discussing type 2 diabetes online

29.09.2023 | Article

Understanding conversation networks within online HCP communities

There is a significant cluster of highly conversation-connected cardiology specialists

By Francesca Gan

Header image for article looking into HCPs' views on AMR and WHO guidance

28.09.2023 | Article

Lessons from WHO on how to disseminate AMR information

What was the response of eHCPs to WHO’s antibiotic book and how are they combatting AMR?

By Francesca Gan

12.06.2023 | Article

Top 50 Pharma tracker review: The importance of knowing what HCPs think.

Looking at the corporate reputation of the Top 50 pharma companies over the past year

By Francesca Gan

On-Demand | Webinars

CREATION.co’s guide to identifying and tackling health misinformation on social media

How can pharma support HCPs in tackling medical misinformation online?

By Jamie Doggett and Francesca Gan

31.01.2023 | Article

Lecanemab: Full phase 3 trial results for the Alzheimer’s disease drug not…

HCP conversations on Phase 3 trial data for lecanemab for Alzheimers has been shifting

By Francesca Gan

05.01.2023 | Article

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma…

The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....

By Francesca Gan

18.12.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent…

In Nov 2022 there was a 22% decrease in HCP pharma mentions from the previous month

By Francesca Gan

14.11.2022 | Article

Top 50 Pharma Tracker: HCPs actively discussed issues concerning mRNA and bivalent…

The FDA granted emergency use of Pfizer and Moderna's bivalent vaccine in children

By Francesca Gan

05.10.2022 | Article

Top 50 Pharma Tracker: Bivalent vaccine data and new treatments drive HCP…

The latest developments in the Top 50 tracker saw GSK jump back amongst the Top 5.

By Francesca Gan and Chawanzi Chintu

05.09.2022 | Article

Top 50 Pharma Tracker: HCPs discuss bivalent vaccine approval in the UK…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

18.08.2022 | Article

HCPs share frustrations on access and funding issues plaguing the NHS

The NHS has not escaped access and funding issues, and given that it is completely govern...

By Francesca Gan

04.08.2022 | Article

Top 50 Pharma Tracker: HCPs continue to discuss Moderna’s COVID-19 vaccine but…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

02.07.2022 | Article

Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

29.06.2022 | Article

HCPs raise 5 concerns related to long covid

Common issues experienced by sufferers of long covid include, amongst others, fatigue...

By Francesca Gan

06.06.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Pfizer vaccine documents and share opinions…

Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing...

By Francesca Gan and Chawanzi Chintu

05.05.2022 | Article

Top 50 Pharma Tracker: HCPs celebrate the success of Lilly’s tirzepatide for…

Notably this month, HCPs celebrated the efficacy of Lilly’s tirzepatide for obesity patients

By Francesca Gan and Chawanzi Chintu

14.04.2022 | Article

HCPs show concern for racial inequity issues in sickle cell treatment

This is a big issue as SCD is one of the most prevalent genetic diseases, and thus raises...

By Francesca Gan

13.04.2022 | Article

Top 50 Pharma Tracker: HCPs compare immune responses of T cell, B…

Conversations still largely revolved around vaccine efficacy, with HCPs sharing various...

By Francesca Gan and Chawanzi Chintu

11.03.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Healthcare inequity and vaccination of under…

HCPs largely discussed healthcare inequity, comparing the revenue of pharmaceutical...

By Francesca Gan and Chawanzi Chintu

22.02.2022 | Article

What do HCPs think about a fourth COVID vaccine

What do HCPs think about a fourth COVID vaccine

By Francesca Gan

08.02.2022 | Article

Top 50 Pharma Tracker: HCPs get political when discussing Regeneron’s COVID-19 treatment

HCPs get political when discussing Regeneron’s COVID-19 treatment

By Francesca Gan and Chawanzi Chintu

11.01.2022 | Article

Top 50 Pharma Tracker: Omicron variant dominates HCP conversation in December 2021

Discover what healthcare professionals (HCPs) are saying about the Omicron variant

By Francesca Gan and Chawanzi Chintu

22.12.2021 | Article

All HCPs want for Christmas is…

Discover what HCPs wanted for Christmas in 2021

By Paul Cranston and Francesca Gan

01.12.2021 | Article

Top 50 Pharma Tracker: HCPs discuss trial data of Pfizer’s COVID-19 booster…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations

01.10.2021 | Article

Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations

Discover which new drug approvals and launches HCPs are talking about

By Francesca Gan and Chawanzi Chintu